These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12228011)

  • 1. Adenovirus-mediated expression of glucokinase in the liver as an adjuvant treatment for type 1 diabetes.
    Morral N; McEvoy R; Dong H; Meseck M; Altomonte J; Thung S; Woo SL
    Hum Gene Ther; 2002 Sep; 13(13):1561-70. PubMed ID: 12228011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic correction of diabetic mice by adenovirus-mediated glucokinase expression.
    Desai UJ; Slosberg ED; Boettcher BR; Caplan SL; Fanelli B; Stephan Z; Gunther VJ; Kaleko M; Connelly S
    Diabetes; 2001 Oct; 50(10):2287-95. PubMed ID: 11574410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased glucose disposal induced by adenovirus-mediated transfer of glucokinase to skeletal muscle in vivo.
    Jiménez-Chillarón JC; Newgard CB; Gómez-Foix AM
    FASEB J; 1999 Dec; 13(15):2153-60. PubMed ID: 10593862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of liver glucokinase activity in rats with fructose-induced insulin resistance and impaired glucose and lipid metabolism.
    Francini F; Castro MC; Gagliardino JJ; Massa ML
    Can J Physiol Pharmacol; 2009 Sep; 87(9):702-10. PubMed ID: 19794521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMG-123, a novel glucokinase activator, exerts durable effects on hyperglycemia without increasing triglyceride in diabetic animal models.
    Tsumura Y; Tsushima Y; Tamura A; Hasebe M; Kanou M; Kato H; Kobayashi T
    PLoS One; 2017; 12(2):e0172252. PubMed ID: 28207836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle.
    Mas A; Montané J; Anguela XM; Muñoz S; Douar AM; Riu E; Otaegui P; Bosch F
    Diabetes; 2006 Jun; 55(6):1546-53. PubMed ID: 16731816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential role for fructose-2,6-bisphosphate in the stimulation of hepatic glucokinase gene expression.
    Wu C; Okar DA; Stoeckman AK; Peng LJ; Herrera AH; Herrera JE; Towle HC; Lange AJ
    Endocrinology; 2004 Feb; 145(2):650-8. PubMed ID: 14617577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia.
    O'Doherty RM; Lehman DL; Télémaque-Potts S; Newgard CB
    Diabetes; 1999 Oct; 48(10):2022-7. PubMed ID: 10512368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of high-fat diet on glucose homeostasis and gene expression in glucokinase knockout mice.
    Gorman T; Hope DC; Brownlie R; Yu A; Gill D; Löfvenmark J; Wedin M; Mayers RM; Snaith MR; Smith DM
    Diabetes Obes Metab; 2008 Sep; 10(10):885-97. PubMed ID: 18034843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
    Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
    J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic intraperitoneal insulin delivery, as compared with subcutaneous delivery, improves hepatic glucose metabolism in streptozotocin diabetic rats.
    Mason TM; Gupta N; Goh T; El-Bahrani B; Zannis J; van de Werve G; Giacca A
    Metabolism; 2000 Nov; 49(11):1411-6. PubMed ID: 11092503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver.
    Ferre T; Riu E; Bosch F; Valera A
    FASEB J; 1996 Aug; 10(10):1213-8. PubMed ID: 8751724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucokinase gene transfer to skeletal muscle of diabetic Zucker fatty rats improves insulin-sensitive glucose uptake.
    Jiménez-Chillarón JC; Telemaque-Potts S; Gómez-Valadés AG; Anderson P; Newgard CB; Gómez-Foix AM
    Metabolism; 2002 Jan; 51(1):121-6. PubMed ID: 11782883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI).
    Burke CV; Buettger CW; Davis EA; McClane SJ; Matschinsky FM; Raper SE
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):345-52. PubMed ID: 10455021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein.
    Slosberg ED; Desai UJ; Fanelli B; St Denny I; Connelly S; Kaleko M; Boettcher BR; Caplan SL
    Diabetes; 2001 Aug; 50(8):1813-20. PubMed ID: 11473043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and analysis of novel R308K mutation in glucokinase of type 2 diabetic patient and its kinetic correlation.
    Yellapu NK; Valasani KR; Pasupuleti SK; Gopal S; Potukuchi Venkata Gurunadha Krishna S; Matcha B
    Biotechnol Appl Biochem; 2014; 61(5):572-81. PubMed ID: 24447076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats.
    Torres TP; Catlin RL; Chan R; Fujimoto Y; Sasaki N; Printz RL; Newgard CB; Shiota M
    Diabetes; 2009 Jan; 58(1):78-86. PubMed ID: 18952838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic glycogen cycling contributes to glucose lowering effects of the glucokinase activator LCZ960.
    Laurent D; Yerby B; Zhang B; Chen XH; Gounarides J; Zhang J; Gao J; Bebernitz G; Duttaroy A
    Eur J Pharmacol; 2013 Sep; 715(1-3):89-95. PubMed ID: 23816435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of glucokinase in skeletal muscle: a new approach to counteract diabetic hyperglycemia.
    Otaegui PJ; Ferre T; Pujol A; Riu E; Jimenez R; Bosch F
    Hum Gene Ther; 2000 Jul; 11(11):1543-52. PubMed ID: 10945768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule glucokinase activators as novel anti-diabetic agents.
    Leighton B; Atkinson A; Coghlan MP
    Biochem Soc Trans; 2005 Apr; 33(Pt 2):371-4. PubMed ID: 15787609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.